Glucose vs fats (Leslie's sister and Becky):
http://en.wikipedia.org/wiki/Fatty_acid
Most of the natural fatty acids have an even number of carbon atoms, because their
biosynthesis involves
acetyl-CoA, a
coenzyme carrying a two-carbon-atom group (see
fatty acid synthesis).
And
Acetyl-CoA Acetyl-CoA is produced during the second step of aerobic
cellular respiration,
pyruvate decarboxylation, which occurs in the
matrix of the
mitochondria. Acetyl-CoA then enters
Krebs Cycle.
In brief fats are used in the Krebs cycle (aerobic process) only in normal cells. In even more simple term cancer cannot use fats! at least this is what I understand. Should you not agree or have any further info I would appreciate a backed up response to your argument, thank you. To me this is why the trial of high fat diet is being carried out, what else?
Yes AlaskaAngel I am interested about result too.
Regrading your question of how long before killing them off goes back to my initial question. But I have now think that there is no answer to that since it is likely to depend on the particular mutation of the cancer cell. On your question about immune system, I think that by simply cutting off or reducing severly carbohydrate (complex and simple) is the main idea behind this. However enhance immune system when fasting can only be a bonus. Immune system is not systematically damaged by chemo thanks god.
Again I insist I do not think it is a cure and it might work o.1% of the time but hey..
__________________

35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009:
to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama